Variant report
Variant | nsv604072 |
---|---|
Chromosome Location | chr6:81285228-81293161 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs72903959 | chr6:81287642-81287643 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs1454466 | chr6:81287675-81287676 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs566949445 | chr6:81287730-81287731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs182990805 | chr6:81287734-81287735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs552560141 | chr6:81287737-81287738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs141689971 | chr6:81287764-81287765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187680907 | chr6:81287765-81287766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs554612403 | chr6:81287771-81287772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs568100901 | chr6:81287790-81287791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs533866781 | chr6:81287854-81287855 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs9449084 | chr6:81287867-81287868 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs576950344 | chr6:81287868-81287869 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs541553359 | chr6:81287960-81287961 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs539637005 | chr6:81287966-81287967 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556158127 | chr6:81288014-81288015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs576289994 | chr6:81288015-81288016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs553404565 | chr6:81288084-81288085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs192396159 | chr6:81288098-81288099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs78727053 | chr6:81288109-81288110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs138965428 | chr6:81288158-81288159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs534972386 | chr6:81288178-81288179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs562253614 | chr6:81288199-81288200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs540312654 | chr6:81288233-81288234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs73477693 | chr6:81288237-81288238 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs532568609 | chr6:81288264-81288265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs552740764 | chr6:81288292-81288293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs184767134 | chr6:81288311-81288312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs532031729 | chr6:81288337-81288338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs548943738 | chr6:81288414-81288415 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs564125873 | chr6:81288424-81288425 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs533807995 | chr6:81288433-81288434 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs547483891 | chr6:81288485-81288486 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs570550070 | chr6:81288503-81288504 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs578022115 | chr6:81288535-81288536 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs539213776 | chr6:81288553-81288554 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs556333523 | chr6:81288563-81288564 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs576199849 | chr6:81288581-81288582 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs9449085 | chr6:81288614-81288615 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs555271787 | chr6:81288637-81288638 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs62406540 | chr6:81288657-81288658 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs530715597 | chr6:81288678-81288679 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs540252513 | chr6:81288729-81288730 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs560337913 | chr6:81288731-81288732 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs116611188 | chr6:81288797-81288798 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs546019171 | chr6:81288804-81288805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs75164072 | chr6:81288841-81288842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs556735226 | chr6:81288853-81288854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs13198295 | chr6:81288882-81288883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs542471404 | chr6:81288896-81288897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs142101564 | chr6:81288899-81288900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Developmental delay | 21147756 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Lung cancer | 16773561 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Prostate cancer | 16461572 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:81287600-81287800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
2 | chr6:81287800-81288000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr6:81287800-81288800 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
4 | chr6:81288200-81288400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
5 | chr6:81288400-81289400 | Enhancers | HSMM | muscle |
6 | chr6:81288800-81289000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr6:81288800-81289200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr6:81288800-81289200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
9 | chr6:81288800-81289200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr6:81288800-81289200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
11 | chr6:81288800-81289200 | Enhancers | Adipose Nuclei | Adipose |